Ureteral Stents Market Size, Regional Status and Outlook 2026-2035
Ngày đăng: 19-09-2025 |
Ngày cập nhật: 19-09-2025
Ureteral Stents Market Size, Regional Status and Outlook 2026-2035
The worldwide ureteral stents market was valued at USD 528.8 million in 2025 and is forecasted to expand to USD 924.5 million by 2035. This reflects a compound annual growth rate (CAGR) of 6.5% between 2026 and 2035. Market growth is primarily fueled by the growing burden of urological disorders, a rising geriatric population, and continuous product advancements that enhance patient outcomes and physician efficiency.
Ureteral Stents Industry Demand
They are widely used to relieve obstructions, facilitate recovery after urological procedures, and reduce post-operative complications.
Key demand drivers include:
Ureteral Stents Market: Growth Drivers & Key Restraint
Growth Drivers –
Main Growth Drivers
Access Detailed Report@https://www.researchnester.com/sample-request-8031
Ureteral Stents Market: Segment Analysis
Segment Analysis by Product Type –
Segment Analysis by Material–
Segment Analysis by End‑Use–
Ureteral Stents Market: Regional Insights
North America
A technologically advanced and mature market with strong adoption of premium stents. Demand is backed by high procedure volumes, robust healthcare infrastructure, and favorable reimbursement frameworks.
Europe
A diverse market: Western Europe adopts advanced technologies at scale, while Eastern Europe is more price-sensitive. Aging demographics and well-structured healthcare systems sustain stable demand.
Asia-Pacific (APAC)
The fastest-growing region, supported by rising healthcare investments, expanding access to minimally invasive urology, and large patient populations. While cost sensitivity remains, procedural volumes are accelerating, making this region a major growth frontier.
Top Players in the Ureteral Stents Market
Prominent companies shaping the competitive landscape include Boston Scientific Corporation, BD (Becton, Dickinson and Company), Teleflex Incorporated, Cook Medical, Stryker Corporation, Medtronic plc, Karl Storz SE & Co. KG, and Richard Wolf GmbH. These players compete through innovation in stent coatings and biomaterials, global distribution capabilities, and strong hospital relationships, while smaller regional firms provide niche and cost-effective alternatives.
Access Detailed Report@ https://www.researchnester.com/reports/ureteral-stents-market/8031
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
The worldwide ureteral stents market was valued at USD 528.8 million in 2025 and is forecasted to expand to USD 924.5 million by 2035. This reflects a compound annual growth rate (CAGR) of 6.5% between 2026 and 2035. Market growth is primarily fueled by the growing burden of urological disorders, a rising geriatric population, and continuous product advancements that enhance patient outcomes and physician efficiency.
Ureteral Stents Industry Demand
They are widely used to relieve obstructions, facilitate recovery after urological procedures, and reduce post-operative complications.
Key demand drivers include:
- Clinical need: Rising incidence of kidney stones, ureteral blockages, and post-surgical drainage requirements.
- Ease of use: The procedure is minimally invasive, enabling faster recovery compared with open surgeries.
- Product benefits: Improved patient tolerance, reduced risk of encrustation, and simplified placement/removal.
- Economic appeal: Stents are cost-efficient, easy to store, and widely available, making them attractive for both hospitals and outpatient centers.
Ureteral Stents Market: Growth Drivers & Key Restraint
Growth Drivers –
Main Growth Drivers
- Increasing prevalence of urological conditions
Rising cases of kidney stones, strictures, and other urinary tract diseases are boosting the demand for stenting procedures across both developed and emerging markets. - Advances in design and material technologies
The introduction of hydrogel coatings, biodegradable polymers, and anti-encrustation technologies has improved performance, patient comfort, and long-term safety, thereby encouraging wider adoption. - Shift toward outpatient and minimally invasive procedures
The growth of ambulatory surgical centers (ASCs) and greater reliance on ureteroscopy are accelerating the need for short-term, easy-to-manage stents.
- Cost and reimbursement barriers
Premium products such as coated or bioresorbable stents are relatively expensive. Limited or inconsistent reimbursement policies and patient discomfort concerns can hinder widespread adoption in cost-sensitive regions.
Access Detailed Report@https://www.researchnester.com/sample-request-8031
Ureteral Stents Market: Segment Analysis
Segment Analysis by Product Type –
- Double Pigtail Stents: The most widely used due to their versatility and reliable performance across multiple indications.
- Multi-length stents: Increasingly used where anatomical tailoring is necessary and seeing wider adoption in outpatient procedures.
- Open-End Stents: Used for patients requiring better irrigation and drainage; a smaller yet important segment.
- Closed-End Stents: Designed to prevent backflow; their adoption is steady but limited to specific clinical needs.
Segment Analysis by Material–
- Polyurethane: A cost-effective option known for its durability and smooth insertion.
- Silicone: Provides better patient comfort and biocompatibility, though at a higher cost.
- Hydrogel-coated: Minimizes bacterial adhesion and encrustation, suitable for longer indwelling times.
- Other biomaterials (e.g., PEG, biodegradable polymers): Innovative options that reduce the need for secondary removal procedures; considered the most promising future segment.
Segment Analysis by End‑Use–
- Hospitals: Major users due to high surgical volumes and complex cases.
- Ambulatory Surgical Centers (ASCs): Rapidly growing share, driven by cost efficiency and shorter procedure times.
- Specialty Urology Clinics: Influence adoption of advanced stents due to focused expertise.
- Applications include: kidney stone management, treatment of strictures, post-operative drainage, and kidney transplant support.
Ureteral Stents Market: Regional Insights
North America
A technologically advanced and mature market with strong adoption of premium stents. Demand is backed by high procedure volumes, robust healthcare infrastructure, and favorable reimbursement frameworks.
Europe
A diverse market: Western Europe adopts advanced technologies at scale, while Eastern Europe is more price-sensitive. Aging demographics and well-structured healthcare systems sustain stable demand.
Asia-Pacific (APAC)
The fastest-growing region, supported by rising healthcare investments, expanding access to minimally invasive urology, and large patient populations. While cost sensitivity remains, procedural volumes are accelerating, making this region a major growth frontier.
Top Players in the Ureteral Stents Market
Prominent companies shaping the competitive landscape include Boston Scientific Corporation, BD (Becton, Dickinson and Company), Teleflex Incorporated, Cook Medical, Stryker Corporation, Medtronic plc, Karl Storz SE & Co. KG, and Richard Wolf GmbH. These players compete through innovation in stent coatings and biomaterials, global distribution capabilities, and strong hospital relationships, while smaller regional firms provide niche and cost-effective alternatives.
Access Detailed Report@ https://www.researchnester.com/reports/ureteral-stents-market/8031
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
